How can artificial intelligence and machine learning be used to gather and process real-time manufacturing data?
New technologies, such as artificial intelligence and machine learning, are being employed by bio/pharma manufacturers to collect and analyze large amounts of process data in real-time. Hear an expert panel will discuss how this technology can be employed to optimize bio/pharma manufacturing and predictive maintenance.
This Editors’ Series panel discussion, moderated by the editors of Pharmaceutical Technology and BioPharm International, features Bikash Chatterjee, CEO, Pharmatech Associates; Pamela Docherty, life sciences industry manager, Siemens; Amos Dor, general manager of the Pharma team, automation products group, Applied Materials; and Bob Lenich, global life sciences director, Emerson.
The panel discussion—Technology Advances in Process Operations: Using Real-time Montioring and Artificial Intelligence to Optimize Manufacturing Operations was recorded during the 2020 Bio/Pharma Virtual Congress on Nov. 11, 2020.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.